Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Selective and Nonselective HDAC8 Inhibitors: a Therapeutic Patent Review
Nilanjan Adhikari, Sk. Abdul Amin, Tarun Jha
Pharmaceutical Patent Analyst (2018) Vol. 7, Iss. 6, pp. 259-276
Closed Access | Times Cited: 23

Showing 23 citing articles:

Propionate exerts neuroprotective and neuroregenerative effects in the peripheral nervous system
Thomas Grüter, Nuwin Mohamad, Niklas Rilke, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 4
Open Access | Times Cited: 32
Dissecting Histone Deacetylase 3 in Multiple Disease Conditions: Selective Inhibition as a Promising Therapeutic Strategy
Nilanjan Adhikari, Tarun Jha, Balaram Ghosh
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 13, pp. 8827-8869
Closed Access | Times Cited: 46
Histone deacetylase 8 inhibition prevents the progression of peritoneal fibrosis by counteracting the epithelial-mesenchymal transition and blockade of M2 macrophage polarization
Xun Zhou, Hui Chen, Yingfeng Shi, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 17
Discovery of novel N-substituted thiazolidinediones (TZDs) as HDAC8 inhibitors: in-silico studies, synthesis, and biological evaluation
Neha Upadhyay, Kalpana Tilekar, Niklas Jänsch, et al.
Bioorganic Chemistry (2020) Vol. 100, pp. 103934-103934
Open Access | Times Cited: 43
Structure-Based Inhibitor Discovery of Class I Histone Deacetylases (HDACs)
Yuxiang Luo, Huilin Li
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 22, pp. 8828-8828
Open Access | Times Cited: 40
HDAC8 Deacetylates HIF-1α and Enhances Its Protein Stability to Promote Tumor Growth and Migration in Melanoma
Ji Yoon Kim, Hayoung Cho, Jung Yoo, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1123-1123
Open Access | Times Cited: 15
One-Atom Substitution Enables Direct and Continuous Monitoring of Histone Deacylase Activity
Matthes Zessin, Zsófia Kutil, Marat Meleshin, et al.
Biochemistry (2019) Vol. 58, Iss. 48, pp. 4777-4789
Open Access | Times Cited: 37
A patent review of histone deacetylase 8 (HDAC8) inhibitors (2013–present)
Suvankar Banerjee, Balaram Ghosh, Tarun Jha, et al.
Expert Opinion on Therapeutic Patents (2024) Vol. 34, Iss. 10, pp. 1019-1045
Closed Access | Times Cited: 4
Discovery of Potential Selective HDAC8 Binders: Using Combination of Pharmacophore‐Based–Structure‐Based Virtual Screening, ADME Filtration, and Molecular Dynamics Studies
Debashis Roy Chowdhury, Debanjan Sen, S. Roy, et al.
ChemistrySelect (2025) Vol. 10, Iss. 15
Closed Access
Design and synthesis of pyridine-based benzamides as potent HDAC3 inhibitors as an armament against breast cancer with in vivo validation
Ambati Himaja, Ganesh Routholla, Tarun Patel, et al.
European Journal of Medicinal Chemistry (2025) Vol. 291, pp. 117636-117636
Closed Access
HDAC8 As an Emerging Target in Drug Discovery With Special Emphasis on Medicinal Chemistry
S. Rajaraman, Ranjani Balakrishnan, Dhruv Deshmukh, et al.
Future Medicinal Chemistry (2023) Vol. 15, Iss. 10, pp. 885-908
Closed Access | Times Cited: 6
Molecular dynamics study of HDAC8-largazole analogues co-crystals for designing potential anticancer compounds
Varun Dewaker, Pratik Narain Srivastava, Saroj Verma, et al.
Journal of Biomolecular Structure and Dynamics (2019) Vol. 38, Iss. 4, pp. 1197-1213
Closed Access | Times Cited: 13
A comparative quantitative structural assessment of benzothiazine-derived HDAC8 inhibitors by predictive ligand-based drug designing approaches
Suvankar Banerjee, Sandip Kumar Baidya, Nilanjan Adhikari, et al.
SAR and QSAR in environmental research (2022) Vol. 33, Iss. 12, pp. 987-1011
Closed Access | Times Cited: 8
Hydrazides as Potential HDAC Inhibitors: Structure-activity Relationships and Biological Implications
Suvankar Banerjee, Sandip Kumar Baidya, Nilanjan Adhikari, et al.
Current Topics in Medicinal Chemistry (2023) Vol. 23, Iss. 25, pp. 2343-2372
Closed Access | Times Cited: 4
Essential elements regulating HDAC8 inhibition: a classification based structural analysis and enzyme-inhibitor interaction study of hydroxamate based HDAC8 inhibitors
Suvankar Banerjee, Sk. Abdul Amin, Nilanjan Adhikari, et al.
Journal of Biomolecular Structure and Dynamics (2019) Vol. 38, Iss. 18, pp. 5513-5525
Closed Access | Times Cited: 11
Slow-Binding and Covalent HDAC Inhibition: A New Paradigm?
Yasir S. Raouf, Carlos Moreno–Yruela
JACS Au (2024) Vol. 4, Iss. 11, pp. 4148-4161
Open Access | Times Cited: 1
Discriminations of active from inactive HDAC8 inhibitors Part II: Bayesian classification study to find molecular fingerprints
Sk. Abdul Amin, Suvankar Banerjee, Nilanjan Adhikari, et al.
SAR and QSAR in environmental research (2020) Vol. 31, Iss. 4, pp. 245-260
Closed Access | Times Cited: 6
Synthesis, Anticancer Activity, SAR and Binding Mode of Interaction Studies of Substituted Pentanoic Acids: Part II
Sanchita Datta, Amit Kumar Halder, Nilanjan Adhikari, et al.
Future Medicinal Chemistry (2021) Vol. 14, Iss. 1, pp. 17-34
Closed Access | Times Cited: 6
Investigation of HDAC8-ligands’ intermolecular forces through molecular dynamics simulations: profiling of non-bonding energies to design potential compounds as new anti-cancer agents
Varun Dewaker, Ajay Srivastava, Ashish Arora, et al.
Journal of Biomolecular Structure and Dynamics (2020) Vol. 39, Iss. 13, pp. 4726-4751
Closed Access | Times Cited: 4
Nitrogen-containing heterocycles as important scaffold for selective and potent HDAC8 inhibition: a step towards effective, non-toxic and selective HDAC8 inhibitor discovery
Samima Khatun, Rakibul Islam, Sk. Abdul Amin, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-19
Closed Access
Targeting cancers and metabolic disorders: The prospects of combining HDAC8 inhibitor and activator
Mohammed Mukhtar Yusif
European Journal of Medicinal Chemistry Reports (2022) Vol. 7, pp. 100097-100097
Open Access | Times Cited: 2
Decrease in Cell Viability of Breast Cancer Cells by a Di-Hydroxylated Derivative of N-(2-hydroxyphenyl)-2-Propylpentanamide
Norma Lizeth Galindo-Alvarez, Humberto L. Mendoza‐Figueroa, Martha C. Rosales-Hernández, et al.
Anti-Cancer Agents in Medicinal Chemistry (2021) Vol. 22, Iss. 9, pp. 1802-1812
Closed Access | Times Cited: 2
Design, Synthesis and Biological Characterization of Histone Deacetylase 8 (HDAC8) Proteolysis Targeting Chimeras (PROTACs) with Anti-Neuroblastoma Activity
Salma Darwish, Ehab Ghazy, Tino Heimburg, et al.
(2022)
Open Access | Times Cited: 1
Page 1

Scroll to top